Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected

TheMotleyFool

0 0

Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) hope to win Emergency Use Authorization for their COVID-19 vaccine in immunizing children below age 12. Moderna (NASDAQ: MRNA) is pursuing the same goal. In this Motley Fool Live video recorded on July 28, Motley Fool contributors Keith Speights and Brian Orelli discuss why these vaccines won't win authorization for younger kids as soon as expected.

Source Fool.com

Like: 0

PFE

Share